1. Home
  2. AIDX vs CMND Comparison

AIDX vs CMND Comparison

Compare AIDX & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.18

Market Cap

2.9M

Sector

Health Care

ML Signal

N/A

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

N/A

Current Price

$3.04

Market Cap

3.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIDX
CMND
Founded
2000
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Precision Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
3.2M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
AIDX
CMND
Price
$0.18
$3.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 206.0K
5.2K
Earning Date
11-16-2026
09-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 34.48
N/A
EPS
N/A
★ N/A
Revenue
★ $2,045,133.00
N/A
Revenue This Year
$44.20
N/A
Revenue Next Year
$95.73
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 16.71
N/A
52 Week Low
$0.18
$0.07
52 Week High
$18.96
$7.16

Technical Indicators

Market Signals
Indicator
AIDX
CMND
Relative Strength Index (RSI) 30.30 24.30
Support Level N/A $0.58
Resistance Level $0.27 $4.66
Average True Range (ATR) 0.03 0.43
MACD 0.00 -0.41
Stochastic Oscillator 0.00 0.32

Price Performance

Historical Comparison
AIDX
CMND

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Share on Social Networks: